OpenLB
Open Library of Bioscience
Advanced Search
Cell metabolism
Dec 07, 2021;33 (12): 2484.

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.

Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D Lau, Luis G Gomez-Escobar, Lunkun Ma, Ankit Gilani, Sergio Alvarez-Mulett, Evan T Sholle, Vasuretha Chandar, Yaron Bram, Katherine Hoffman, Priya Bhardwaj, Phoebe Piloco, Alfonso Rubio-Navarro, Skyler Uhl, Lucia Carrau, Sean Houhgton, David Redmond, Alpana P Shukla, Parag Goyal, Kristy A Brown, Benjamin R tenOever, Laura C Alonso, Robert E Schwartz, Edward J Schenck, Monika M Safford, James C Lo
Author Information
PMID: 34879241 DOI: 10.1016/j.cmet.2021.10.014

Abstract

No abstract text available.

Grants

  1. R01 DK121140/NIDDK NIH HHS
  2. R01 DK121844/NIDDK NIH HHS
  3. R01 DK121072/NIDDK NIH HHS
  4. UL1 TR002384/NCATS NIH HHS
  5. R01 CA215797/NCI NIH HHS
Published Erratum

Links to CNCB-NGDC Resources

GEN: GEND000384 (Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance)

Word Cloud

Similar Articles

Cited By